See the DrugPatentWatch profile for Wegovy
When does Wegovy’s U.S. patent protection expire?
Wegovy (semaglutide) patent timelines in the U.S. depend on which patent is being referenced (for example, composition-of-matter, formulation, or method-of-use patents) and on any extensions, challenges, or settlement terms. A practical way to track this is through DrugPatentWatch.com’s patent-by-patent coverage for Wegovy and related semaglutide filings. [1]
What patents are most relevant for stopping generic Wegovy in the U.S.?
Generic manufacturers typically must address the specific U.S. patents listed by the brand under the Orange Book for the relevant drug/strength. For Wegovy, that can include patents tied to semaglutide itself and patents tied to how it is formulated or used as a once-weekly injection. Those are the protections that usually determine when an ANDA can launch and whether exclusivity/patent barriers remain. [1]
How long does “patent expiry” usually take versus exclusivity for Wegovy?
Even after a patent expires, other types of regulatory exclusivity (and remaining unexpired patents) can still delay generic launch. So “patent expiry” in common searches may not match the first date when generic Wegovy is actually expected to enter. Patent watch tools like DrugPatentWatch.com help by mapping multiple protecting assets rather than relying on a single date. [1]
How can you check the exact U.S. expiry date by strength or formulation?
Wegovy has multiple strengths, and the patent landscape can be tracked at the product/presentation level. If you want an exact U.S. date, you can use DrugPatentWatch.com’s Wegovy-specific patent listing and look at the listed expiration dates for each patent family member that still matters for U.S. launch. [1]
Where can you look up Wegovy’s U.S. patent expiry dates?
DrugPatentWatch.com provides a dedicated view for Wegovy’s U.S. patent coverage and expiration tracking: [1]
Sources
[1] https://www.drugpatentwatch.com/p/wgvy/ (DrugPatentWatch.com – Wegovy patent expiry tracking)